End-of-day quote
Other stock markets
|
||
- RON | - |
|
06-06 | Antibiotice S.A. announced that it expects to receive $108.96 million in funding | CI |
05-15 | Antibiotice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 497M 107M 8.47B | Sales 2023 | 615M 132M 10.48B | Capitalization | 937M 202M 15.94B |
---|---|---|---|---|---|
Net income 2022 | 38M 8.18M 647M | Net income 2023 | 81M 17.44M 1.38B | EV / Sales 2022 | 0.92 x |
Net Debt 2022 | 79.25M 17.06M 1.35B | Net Debt 2023 | 64.49M 13.88M 1.1B | EV / Sales 2023 | 1.63 x |
P/E ratio 2022 |
9.87
x | P/E ratio 2023 |
11.5
x | Employees | - |
Yield 2022 |
1.4% | Yield 2023 |
3.3% | Free-Float | 17.57% |
Managers | Title | Age | Since |
---|---|---|---|
Ioan Nani
CEO | Chief Executive Officer | 64 | 31/12/86 |
Director of Finance/CFO | 56 | 31/12/90 | |
Cornelia Moraru
CTO | Chief Tech/Sci/R&D Officer | 58 | 04/01/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ioan Nani
CEO | Chief Executive Officer | 64 | 31/12/86 |
Mihai Trifu
BRD | Director/Board Member | 41 | 25/08/21 |
Director/Board Member | 48 | 25/08/21 |
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |